文献速递关节外科

静脉注射对乙酰氨基酚在全膝关节置换术多模式镇痛中的应用:一项随机、双盲、安慰剂对照试验

Intravenous Acetaminophen in Multimodal Pain Management for Patients Undergoing Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
PubMed 文献 · J Arthroplasty · 2017-05-15

该随机双盲安慰剂对照试验纳入67例单侧全膝关节置换术患者,比较静脉注射对乙酰氨基酚1000 mg每6小时一次与生理盐水在围手术期多模式镇痛(含关节周围多药注射及静脉和口服非甾体抗炎药)基础上的镇痛效果。意向性分析显示,术后第1天17:00对乙酰氨基酚组疼痛评分显著优于安慰剂组(15.3±17.0 mm vs 26.8±19.0 mm,P=0.013),两组并发症发生率无显著差异。

要点

  • 静脉对乙酰氨基酚组术后第1天17:00疼痛评分15.3±17.0 mm,显著低于安慰剂组26.8±19.0 mm(P=0.013)。
  • 两组并发症发生率无显著差异。
  • 即使在使用关节周围多药注射的多模式镇痛背景下,静脉对乙酰氨基酚仍提供更好的疼痛缓解。

核心结论

  • 即使在使用包括关节周围多药注射的多模式镇痛管理背景下,静脉注射对乙酰氨基酚仍为接受单侧全膝关节置换术的患者提供更好的疼痛缓解。

研究设计与样本

  • 随机、双盲、安慰剂对照试验,纳入67例计划接受单侧全膝关节置换术的患者。
  • 患者随机接受静脉注射对乙酰氨基酚1000 mg每6小时一次或生理盐水相同间隔给药。
  • 所有患者均接受术中关节周围多药注射以及静脉和口服非甾体抗炎药治疗。

主要发现

  • 意向性分析中,术后第1天17:00静脉对乙酰氨基酚组疼痛评分显著优于安慰剂组(15.3±17.0 mm vs 26.8±19.0 mm;P=0.013)。
  • 两组并发症发生率无显著差异。

关键数值与推荐

  • 主要结局为给药时术后100 mm视觉模拟疼痛量表评分。
  • 静脉对乙酰氨基酚组术后第1天17:00疼痛评分为15.3±17.0 mm,安慰剂组为26.8±19.0 mm(P=0.013)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although multimodal pain management including periarticular multidrug injection can provide excellent pain relief in the early postoperative period after total knee arthroplasty (TKA), rebounding pain remains an important challenge. A randomized, double-blind, placebo-controlled trial was performed to investigate the efficacy of adding intravenous acetaminophen to multimodal pain management for TKA. METHODS: We enrolled 67 patients scheduled for unilateral TKA. Patients were randomly assigned to receive either 1000 mg of intravenous acetaminophen at 6-hour intervals or normal saline at the same intervals. All patients were treated with intraoperative periarticular multidrug injection and intravenous and oral nonsteroidal anti-inflammatory drugs. The primary outcome was the postoperative 100-mm visual analog pain scale at the time of administration of study drugs. RESULTS: In the intention-to-treat analysis, the pain score was significantly better in the intravenous acetaminophen group than the placebo group at 17:00 one day after TKA (15.3 ± 17.0 mm vs 26.8 ± 19.0 mm; P = .013). There were no significant differences in terms of the rate of complications between groups. CONCLUSION: Even in the setting of multimodal pain management including periarticular multidrug injection, intravenous acetaminophen provided better pain relief for patients undergoing unilateral TKA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Murata-Ooiwa M, Tsukada S, Wakui M, et al. Intravenous Acetaminophen in Multimodal Pain Management for Patients Undergoing Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial. J Arthroplasty. 2017. PMID: 28583757. doi:10.1016/j.arth.2017.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。